Alkermes plc (ALKS)
USD 28.19
(-4.41%)
USD 28.19
(-4.41%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.37 Billion USD | 53.82% |
| 2022 | 893.68 Million USD | 56.83% |
| 2021 | 569.83 Million USD | 22.32% |
| 2020 | 465.85 Million USD | -2.49% |
| 2019 | 477.72 Million USD | -2.99% |
| 2018 | 492.44 Million USD | 46.68% |
| 2017 | 335.73 Million USD | 48.28% |
| 2016 | 226.42 Million USD | 56.22% |
| 2015 | 144.94 Million USD | -15.2% |
| 2014 | 170.91 Million USD | -35.52% |
| 2013 | 265.06 Million USD | 1.02% |
| 2012 | 262.39 Million USD | 95.16% |
| 2011 | 134.45 Million USD | 4.36% |
| 2010 | 128.84 Million USD | -54.54% |
| 2009 | 283.44 Million USD | 41.69% |
| 2008 | 200.04 Million USD | 2.71% |
| 2007 | 194.75 Million USD | 36.09% |
| 2006 | 143.11 Million USD | 141.37% |
| 2005 | 59.29 Million USD | 196.2% |
| 2004 | 20.01 Million USD | -44.94% |
| 2003 | 36.35 Million USD | -32.8% |
| 2002 | 54.1 Million USD | -3.44% |
| 2001 | 56.02 Million USD | 144.45% |
| 2000 | 22.92 Million USD | -47.57% |
| 1999 | 43.71 Million USD | 39.55% |
| 1998 | 31.32 Million USD | 58.0% |
| 1997 | 19.82 Million USD | 20.9% |
| 1996 | 16.4 Million USD | 13.1% |
| 1995 | 14.5 Million USD | 36.79% |
| 1994 | 10.6 Million USD | 285.96% |
| 1993 | -5.7 Million USD | -21.28% |
| 1992 | -4.7 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 289.26 Million USD | -3.04% |
| 2024 Q3 | 315.04 Million USD | -6.31% |
| 2024 Q2 | 336.24 Million USD | 16.24% |
| 2023 Q4 | 298.35 Million USD | -6.6% |
| 2023 Q1 | 229.42 Million USD | -8.49% |
| 2023 Q2 | 453.34 Million USD | 97.61% |
| 2023 FY | 1.37 Billion USD | 53.82% |
| 2023 Q3 | 319.42 Million USD | -29.54% |
| 2022 FY | 893.68 Million USD | 56.83% |
| 2022 Q1 | 127.43 Million USD | -26.09% |
| 2022 Q2 | 217.85 Million USD | 70.96% |
| 2022 Q3 | 101.3 Million USD | -53.5% |
| 2022 Q4 | 250.71 Million USD | 147.49% |
| 2021 Q1 | 118.14 Million USD | -5.46% |
| 2021 FY | 569.83 Million USD | 22.32% |
| 2021 Q2 | 153.12 Million USD | 29.61% |
| 2021 Q3 | 126.16 Million USD | -17.6% |
| 2021 Q4 | 172.4 Million USD | 36.65% |
| 2020 Q1 | 105.73 Million USD | -37.1% |
| 2020 Q2 | 108.25 Million USD | 2.39% |
| 2020 Q3 | 126.9 Million USD | 17.23% |
| 2020 Q4 | 124.96 Million USD | -1.53% |
| 2020 FY | 465.85 Million USD | -2.49% |
| 2019 Q3 | 105.25 Million USD | -18.54% |
| 2019 Q2 | 129.21 Million USD | 71.89% |
| 2019 FY | 477.72 Million USD | -2.99% |
| 2019 Q1 | 75.17 Million USD | -52.32% |
| 2019 Q4 | 168.09 Million USD | 59.7% |
| 2018 Q3 | 108.04 Million USD | -30.02% |
| 2018 Q1 | 72.32 Million USD | -45.36% |
| 2018 FY | 492.44 Million USD | 46.68% |
| 2018 Q4 | 157.67 Million USD | 45.93% |
| 2018 Q2 | 154.4 Million USD | 113.47% |
| 2017 Q4 | 132.37 Million USD | 72.09% |
| 2017 FY | 335.73 Million USD | 48.28% |
| 2017 Q1 | 46.53 Million USD | -47.68% |
| 2017 Q2 | 79.91 Million USD | 71.74% |
| 2017 Q3 | 76.92 Million USD | -3.75% |
| 2016 Q4 | 88.93 Million USD | 96.14% |
| 2016 Q3 | 45.34 Million USD | -29.33% |
| 2016 FY | 226.42 Million USD | 56.22% |
| 2016 Q2 | 64.16 Million USD | 129.22% |
| 2016 Q1 | 27.99 Million USD | -19.15% |
| 2015 Q1 | 50.96 Million USD | -6.25% |
| 2015 FY | 144.94 Million USD | -15.2% |
| 2015 Q4 | 34.62 Million USD | 31.69% |
| 2015 Q3 | 26.28 Million USD | -20.5% |
| 2015 Q2 | 33.07 Million USD | -35.11% |
| 2014 FY | 170.91 Million USD | -35.52% |
| 2014 Q1 | 39.23 Million USD | -66.46% |
| 2014 Q2 | 42.92 Million USD | 9.42% |
| 2014 Q4 | 54.36 Million USD | 58.05% |
| 2014 Q3 | 34.39 Million USD | -19.88% |
| 2013 Q3 | 48.43 Million USD | -18.16% |
| 2013 Q1 | 79.63 Million USD | 21.25% |
| 2013 FY | 265.06 Million USD | 1.02% |
| 2013 Q4 | 116.98 Million USD | 141.55% |
| 2013 Q2 | 59.17 Million USD | -25.68% |
| 2012 FY | 262.39 Million USD | 95.16% |
| 2012 Q4 | 65.67 Million USD | -20.38% |
| 2012 Q3 | 82.48 Million USD | -25.13% |
| 2012 Q2 | 110.16 Million USD | 38.76% |
| 2012 Q1 | 79.39 Million USD | -4.22% |
| 2011 Q3 | 54.44 Million USD | 19.24% |
| 2011 Q4 | 82.89 Million USD | 52.24% |
| 2011 FY | 134.45 Million USD | 4.36% |
| 2011 Q2 | 45.66 Million USD | 18.95% |
| 2011 Q1 | 38.38 Million USD | 23.38% |
| 2010 FY | 128.84 Million USD | -54.54% |
| 2010 Q1 | 26.86 Million USD | -21.16% |
| 2010 Q4 | 31.11 Million USD | -11.95% |
| 2010 Q3 | 35.33 Million USD | 19.32% |
| 2010 Q2 | 29.61 Million USD | 10.22% |
| 2009 Q2 | 34.83 Million USD | 7.5% |
| 2009 Q1 | 32.4 Million USD | -78.42% |
| 2009 FY | 283.44 Million USD | 41.69% |
| 2009 Q4 | 34.08 Million USD | 3.07% |
| 2009 Q3 | 33.06 Million USD | -5.07% |
| 2008 Q1 | 48.59 Million USD | 12.3% |
| 2008 Q3 | 35.24 Million USD | -46.34% |
| 2008 Q4 | 150.12 Million USD | 326.01% |
| 2008 FY | 200.04 Million USD | 2.71% |
| 2008 Q2 | 65.67 Million USD | 35.16% |
| 2007 Q4 | 43.27 Million USD | -12.37% |
| 2007 Q2 | 58.79 Million USD | 9.31% |
| 2007 Q1 | 53.78 Million USD | 8.82% |
| 2007 FY | 194.75 Million USD | 36.09% |
| 2007 Q3 | 49.38 Million USD | -16.01% |
| 2006 Q4 | 49.42 Million USD | 0.15% |
| 2006 Q3 | 49.34 Million USD | 16.94% |
| 2006 Q2 | 42.2 Million USD | -6.48% |
| 2006 Q1 | 45.12 Million USD | 27.68% |
| 2006 FY | 143.11 Million USD | 141.37% |
| 2005 FY | 59.29 Million USD | 196.2% |
| 2005 Q4 | 35.34 Million USD | -16.51% |
| 2005 Q1 | 18.76 Million USD | 0.56% |
| 2005 Q2 | 20.32 Million USD | 8.32% |
| 2005 Q3 | 42.32 Million USD | 108.3% |
| 2004 Q4 | 18.65 Million USD | 19.24% |
| 2004 Q1 | 8.24 Million USD | 15.24% |
| 2004 FY | 20.01 Million USD | -44.94% |
| 2004 Q2 | 6.23 Million USD | -24.37% |
| 2004 Q3 | 15.64 Million USD | 150.99% |
| 2003 Q1 | 12.3 Million USD | -18.99% |
| 2003 Q3 | 2.88 Million USD | 65.63% |
| 2003 Q4 | 7.15 Million USD | 148.04% |
| 2003 FY | 36.35 Million USD | -32.8% |
| 2003 Q2 | 1.74 Million USD | -85.86% |
| 2002 FY | 54.1 Million USD | -3.44% |
| 2002 Q4 | 15.19 Million USD | 60.43% |
| 2002 Q1 | 12.61 Million USD | 10.19% |
| 2002 Q2 | 10.29 Million USD | -18.45% |
| 2002 Q3 | 9.47 Million USD | -7.97% |
| 2001 FY | 56.02 Million USD | 144.45% |
| 2001 Q3 | 14.5 Million USD | -6.58% |
| 2001 Q1 | 9.85 Million USD | 1.76% |
| 2001 Q2 | 15.52 Million USD | 57.48% |
| 2001 Q4 | 11.45 Million USD | -21.05% |
| 2000 Q2 | 28.96 Million USD | 1865.91% |
| 2000 FY | 22.92 Million USD | -47.57% |
| 2000 Q4 | 9.68 Million USD | 28.94% |
| 2000 Q1 | -1.64 Million USD | -117.27% |
| 2000 Q3 | 7.51 Million USD | -74.06% |
| 1999 FY | 43.71 Million USD | 39.55% |
| 1999 Q3 | 6.84 Million USD | -16.78% |
| 1999 Q2 | 8.22 Million USD | 6.24% |
| 1999 Q1 | 7.73 Million USD | -42.89% |
| 1999 Q4 | 9.49 Million USD | 38.78% |
| 1998 Q1 | 9.15 Million USD | 17.32% |
| 1998 FY | 31.32 Million USD | 58.0% |
| 1998 Q4 | 13.55 Million USD | 11.42% |
| 1998 Q3 | 12.16 Million USD | 18.56% |
| 1998 Q2 | 10.25 Million USD | 12.04% |
| 1997 Q1 | 5.81 Million USD | 5.72% |
| 1997 FY | 19.82 Million USD | 20.9% |
| 1997 Q4 | 7.8 Million USD | -7.45% |
| 1997 Q3 | 8.43 Million USD | 42.18% |
| 1997 Q2 | 5.93 Million USD | 1.92% |
| 1996 Q3 | 4.08 Million USD | -7.64% |
| 1996 Q4 | 5.5 Million USD | 34.86% |
| 1996 Q2 | 4.41 Million USD | -13.33% |
| 1996 Q1 | 5.1 Million USD | 41.67% |
| 1996 FY | 16.4 Million USD | 13.1% |
| 1995 Q2 | 4.1 Million USD | 5.13% |
| 1995 Q1 | 3.9 Million USD | -7.14% |
| 1995 Q4 | 3.6 Million USD | 0.0% |
| 1995 FY | 14.5 Million USD | 36.79% |
| 1995 Q3 | 3.6 Million USD | -12.2% |
| 1994 FY | 10.6 Million USD | 285.96% |
| 1994 Q4 | 4.2 Million USD | 16.67% |
| 1994 Q3 | 3.6 Million USD | 24.14% |
| 1994 Q2 | 2.9 Million USD | -84.9% |
| 1994 Q1 | 19.2 Million USD | 811.11% |
| 1993 Q4 | -2.7 Million USD | -22.73% |
| 1993 Q1 | 2.8 Million USD | 3.7% |
| 1993 FY | -5.7 Million USD | -21.28% |
| 1993 Q2 | -3.6 Million USD | -228.57% |
| 1993 Q3 | -2.2 Million USD | 38.89% |
| 1992 Q3 | -1.7 Million USD | -142.86% |
| 1992 FY | -4.7 Million USD | 0.0% |
| 1992 Q2 | -700 Thousand USD | -200.0% |
| 1992 Q1 | 700 Thousand USD | 0.0% |
| 1992 Q4 | 2.7 Million USD | 258.82% |
| 1991 Q4 | 700 Thousand USD | 163.64% |
| 1991 Q2 | -800 Thousand USD | 0.0% |
| 1991 Q3 | -1.1 Million USD | -37.5% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -1041.059% |
| Jaguar Health, Inc. | 7.72 Million USD | -17697.501% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 207129.97% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 27493680.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 9.435% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -1047.929% |
| ContextLogic Inc. | 59 Million USD | -2229.964% |
| MiMedx Group, Inc. | 266.84 Million USD | -415.164% |
| MEI Pharma, Inc. | 49.32 Million USD | -2686.869% |
| AlloVir, Inc. | -398 Thousand USD | 345496.734% |
| Novavax, Inc. | 639.93 Million USD | -114.815% |
| Aptorum Group Limited | -1.11 Million USD | 123424.105% |
| Ardelyx, Inc. | 106.66 Million USD | -1188.83% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -471.034% |
| Psyence Biomedical Ltd. | -240.00 USD | 572783016.667% |
| Vaxcyte, Inc. | -75 Million USD | 1932.905% |
| Precigen, Inc. | 106 Thousand USD | -1296766.981% |
| Pharming Group N.V. | 220.1 Million USD | -524.559% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -266827.961% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -136141.724% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -1152.304% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 857.783% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 266126.055% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 1161.364% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 3132.938% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 6352.235% |
| Acelyrin, Inc. | -115 Thousand USD | 1195473.043% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 240849.387% |
| Senti Biosciences, Inc. | -2.68 Million USD | 51336.638% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -33834.313% |
| AbCellera Biologics Inc. | 38.02 Million USD | -3515.198% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 28751.084% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -1145465.833% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -4619.28% |
| Chimerix, Inc. | 324 Thousand USD | -424183.642% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -277053.024% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1676537.805% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 4510.594% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 279506.301% |
| Elevation Oncology, Inc. | -39 Thousand USD | 3524917.949% |
| Fortress Biotech, Inc. | 57.85 Million USD | -2276.159% |
| Fortress Biotech, Inc. | 57.85 Million USD | -2276.159% |
| Agenus Inc. | 139.61 Million USD | -884.621% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -8192.689% |
| Dyadic International, Inc. | 922.95 Thousand USD | -148842.908% |
| ImmuCell Corporation | 4.39 Million USD | -31169.113% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -6427.131% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 1395.364% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 786336.223% |
| Immix Biopharma, Inc. | -5468.00 USD | 25140535.26% |
| Incyte Corporation | 3.44 Billion USD | 60.046% |
| IO Biotech, Inc. | -756 Thousand USD | 181935.847% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 3034.903% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 10391.171% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 3111078.094% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 1499.634% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 2499516.364% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -171306.359% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 260949.905% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -4577.847% |
| NextCure, Inc. | -3.68 Million USD | 37414.848% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -7118.815% |
| Onconetix, Inc. | -1.12 Million USD | 122058.986% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 4845.509% |
| Opthea Limited | 21.72 Thousand USD | -6328993.002% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 2398102.652% |
| PureTech Health plc | -1.6 Million USD | 85856.644% |
| Pyxis Oncology, Inc. | -2 Million USD | 68833.95% |
| Seer, Inc. | 7.02 Million USD | -19462.815% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 13677137.111% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -17365.112% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 34972.203% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -324116.745% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -1220.55% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -916.256% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 1517.926% |
| ChromaDex Corporation | 50.78 Million USD | -2607.127% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 592634.052% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 1871.539% |
| CRISPR Therapeutics AG | 240.95 Million USD | -470.51% |
| Precision BioSciences, Inc. | 40.47 Million USD | -3296.617% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 1500.404% |
| Innoviva, Inc. | 261.06 Million USD | -426.566% |
| Summit Therapeutics Inc. | -2.05 Million USD | 67157.512% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -31299.703% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -6280.501% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 1160254.78% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 959394.771% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -225627.258% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -338.254% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -53306.333% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 2709360.938% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 19467.132% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 289783.592% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 13218167.308% |
| Soligenix, Inc. | 97.31 Thousand USD | -1412565.577% |
| Century Therapeutics, Inc. | -10.8 Million USD | 12817.911% |
| Kura Oncology, Inc. | -849 Thousand USD | 162017.432% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 2148.58% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 935255.782% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1288.018% |
| Autolus Therapeutics plc | -4.86 Million USD | 28344.894% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -3221.604% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 818361.31% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -1351.262% |
| GRI Bio, Inc. | 10.84 Million USD | -12580.371% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -54021.519% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 15924.554% |
| IGM Biosciences, Inc. | -211.66 Million USD | 749.475% |
| INmune Bio, Inc. | 155 Thousand USD | -886789.677% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -2119.408% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 91362.512% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 212093.295% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 4696004.215% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -341859.95% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 68971.693% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 439294.569% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -1355.287% |
| Verastem, Inc. | -62 Thousand USD | 2217324.194% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -56354.99% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 526796.935% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -45313.908% |
| Histogen Inc. | 3.76 Million USD | -36373.309% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -238485.405% |
| Surrozen, Inc. | -27.23 Million USD | 5148.399% |
| Organovo Holdings, Inc. | -5.38 Million USD | 25608.981% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 114192.607% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 5459.999% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -6755.571% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 69428332.323% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -22560.454% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 2047855.88% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -788.087% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -942752.538% |
| Apollomics, Inc. | 127 Thousand USD | -1082324.409% |
| Amarin Corporation plc | 165.54 Million USD | -730.416% |
| Mesoblast Limited | -9.81 Million USD | 14105.899% |
| Turnstone Biologics Corp. | 16.5 Million USD | -8228.359% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1344.177% |
| Synaptogenix, Inc. | -6347.00 USD | 21658820.655% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 2695549.02% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -751.907% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 21.789% |
| Better Therapeutics, Inc. | -2.72 Million USD | 50472.994% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1325.63% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -306.612% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 12050231.487% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 22059.728% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 124168.502% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -18684.898% |
| Insmed Incorporated | 239.63 Million USD | -473.655% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -38320.319% |
| OmniAb, Inc. | 14.66 Million USD | -9272.598% |
| Alector, Inc. | -95.05 Million USD | 1546.224% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -994.307% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 3262.872% |
| Zai Lab Limited | 170.9 Million USD | -704.362% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -1578.956% |
| Aura Biosciences, Inc. | -1.29 Million USD | 106252.819% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1057345.385% |
| Immunic, Inc. | -111 Thousand USD | 1238549.55% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -8570.865% |
| Veracyte, Inc. | 248.14 Million USD | -453.975% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 119.669% |
| FibroGen, Inc. | 128.9 Million USD | -966.436% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 243737511.348% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 11882.742% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 59.552% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -353287.918% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -286.858% |
| TG Therapeutics, Inc. | 219.1 Million USD | -527.398% |
| Galecto, Inc. | -830 Thousand USD | 165723.976% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 99354.801% |
| Fortrea Holdings Inc. | 424 Million USD | -224.217% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 1695.366% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 242547.795% |
| XBiotech Inc. | -1.74 Million USD | 78923.337% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 124168.502% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 3058.144% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 1919.947% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -1772.783% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -8081.152% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -253.352% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 2868.906% |
| Vaxxinity, Inc. | -2.23 Million USD | 61634.423% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -320.711% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 12239.687% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -5522.179% |
| NexImmune, Inc. | -1.02 Million USD | 134218.688% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -25456918.519% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 19446.264% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 87.836% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 2057171.244% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 38812.447% |
| Ainos, Inc. | -253.73 Thousand USD | 541881.715% |
| Pluri Inc. | 322 Thousand USD | -426818.944% |
| Prothena Corporation plc | -129.2 Million USD | 1163.985% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -2626.243% |
| Celularity Inc. | 6.75 Million USD | -20250.54% |
| Rallybio Corporation | -150 Thousand USD | 916552.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 4315.901% |
| MeiraGTx Holdings plc | 287 Thousand USD | -478882.23% |
| Omeros Corporation | -69.77 Million USD | 2070.047% |
| Humacyte, Inc. | -76.55 Million USD | 1895.792% |
| Immunocore Holdings plc | 248.39 Million USD | -453.433% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 9162.423% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -2103.647% |
| Blueprint Medicines Corporation | 236.58 Million USD | -481.053% |
| CalciMedica, Inc. | -58 Thousand USD | 2370236.207% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 96501.052% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -4631.299% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 48436.111% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 4553.844% |
| Pulmatrix, Inc. | -8.22 Million USD | 16823.589% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 117593.932% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 344631.078% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 444.709% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -49427.541% |
| Cytokinetics, Incorporated | -322.59 Million USD | 526.134% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -159356.099% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 403231.672% |
| Vor Biopharma Inc. | -3.49 Million USD | 39466.523% |
| Roivant Sciences Ltd. | 109.23 Million USD | -1158.46% |
| Evogene Ltd. | 1.39 Million USD | -98161.544% |
| ProKidney Corp. | -3.16 Million USD | 43478.952% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 3230.532% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -19947.82% |
| CorMedix Inc. | -205.56 Thousand USD | 668841.791% |
| BioLineRx Ltd. | 1.1 Million USD | -123968.502% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 1847.377% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 4165793.939% |
| Atai Life Sciences N.V. | -5000.00 USD | 27493680.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 1128189.842% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 1432057.292% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 99068.97% |
| Sagimet Biosciences Inc. | 2 Million USD | -68633.95% |
| MediciNova, Inc. | 979.7 Thousand USD | -140215.605% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 1730.331% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1453940.622% |
| GeoVax Labs, Inc. | -20.72 Million USD | 6734.306% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -462.16% |
| Biomea Fusion, Inc. | -4.2 Million USD | 32822.661% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -57.586% |
| Mereo BioPharma Group plc | 7.42 Million USD | -18411.702% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 443544.839% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 11455758.333% |
| Absci Corporation | -41.84 Million USD | 3384.855% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 27493680.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 1899.954% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 55958.553% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -543.17% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 146187.035% |
| Allakos Inc. | -6.14 Million USD | 22485.263% |
| Imunon, Inc. | -720 Thousand USD | 191026.313% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 2092.404% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -188.862% |
| BioAtla, Inc. | -103.73 Million USD | 1425.235% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 12050231.487% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 772391.573% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 666.133% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 442118.971% |
| XOMA Corporation | 3.86 Million USD | -35504.222% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 2061.445% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -9192.139% |
| aTyr Pharma, Inc. | -2.38 Million USD | 57666.122% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -10932.737% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 4740372.414% |
| Viridian Therapeutics, Inc. | -1 Million USD | 136476.885% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -10574453746.154% |
| Akari Therapeutics, Plc | -4000.00 USD | 34367075.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -115.842% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -705920.811% |
| UroGen Pharma Ltd. | 73.35 Million USD | -1774.085% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 5249.768% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -11840373.73% |
| Orgenesis Inc. | -5.72 Million USD | 24111.86% |
| Entera Bio Ltd. | -56 Thousand USD | 2454883.929% |
| GH Research PLC | -315 Thousand USD | 436506.032% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 727443.386% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 261943.619% |
| Xencor, Inc. | -85.26 Million USD | 1712.338% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 622191.439% |
| Replimune Group, Inc. | -2.65 Million USD | 51876.987% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 137398.199% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -672.969% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -705920.811% |
| Portage Biotech Inc. | -54 Thousand USD | 2545801.852% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1453940.622% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 364736.34% |
| OncoCyte Corporation | 413 Thousand USD | -332752.058% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 30582502.67% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 619224874.775% |
| Purple Biotech Ltd. | -196 Thousand USD | 701466.837% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -15228.713% |
| scPharmaceuticals Inc. | 9.78 Million USD | -13953.149% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 13261.174% |
| HilleVax, Inc. | -2.15 Million USD | 63860.622% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 1417294.845% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 9162183.444% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 205890.269% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 5976965.217% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 18314111.425% |
| Savara Inc. | -44.26 Million USD | 3205.777% |
| Curis, Inc. | 9.81 Million USD | -13911.609% |
| Daré Bioscience, Inc. | 2.76 Million USD | -49535.966% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 1101711.533% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 79607.172% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 603029.386% |
| BeiGene, Ltd. | 2.07 Billion USD | 33.873% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 49267.674% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 443.959% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -2324.991% |
| Erasca, Inc. | -3.73 Million USD | 36934.914% |
| bluebird bio, Inc. | -4.03 Million USD | 34211.141% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 4871738.67% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 27.815% |
| DBV Technologies S.A. | 15.72 Million USD | -8640.329% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 4871738.67% |
| Moderna, Inc. | 2.15 Billion USD | 36.21% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 150338.142% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -17070.61% |
| Molecular Templates, Inc. | 50.39 Million USD | -2627.808% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 256569.963% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -927.505% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 22193.844% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 3594.088% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1337.023% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 38413.239% |
| MacroGenics, Inc. | 50.52 Million USD | -2620.682% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 22643.112% |
| Prime Medicine, Inc. | -147.9 Million USD | 1029.434% |
| Aditxt, Inc. | -111.66 Thousand USD | 1231229.321% |
| Adagene Inc. | 18.11 Million USD | -7490.093% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -281596.516% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -880.499% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -770.954% |
| SciSparc Ltd. | 2.19 Million USD | -62499.226% |
| Vericel Corporation | 135.57 Million USD | -913.955% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 5488059.599% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 4437124.724% |
| Generation Bio Co. | -73.91 Million USD | 1959.911% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 314671.854% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -2416.851% |
| Invivyd, Inc. | -2.02 Million USD | 67884.961% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 556.945% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 1329088.38% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -1326.489% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -1298.623% |
| ADMA Biologics, Inc. | 88.21 Million USD | -1458.275% |
| Clene Inc. | 533 Thousand USD | -257813.508% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -5601.889% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 143744.619% |
| GeoVax Labs, Inc. | -20.72 Million USD | 6734.306% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -69048.843% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 707545.089% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -2660.122% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 19483.517% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 164535.287% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -1548.0% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -1880137.17% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -2485.83% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 893.75% |
| Trevena, Inc. | 1.45 Million USD | -94379.656% |
| Surrozen, Inc. | -27.23 Million USD | 5148.399% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 389527.479% |
| Cingulate Inc. | -582.91 Thousand USD | 235927.166% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 4434548.387% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 7078.42% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 18159664.069% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 156136.209% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -101.949% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 139237.551% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 2439983.213% |
| Kronos Bio, Inc. | 1.37 Million USD | -100095.262% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 2661.545% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 470880.479% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 281615.377% |
| ImmunityBio, Inc. | -17.89 Million USD | 7784.064% |
| Korro Bio, Inc. | -3.63 Million USD | 37969.945% |
| Kineta, Inc. | 5.43 Million USD | -25202.393% |
| BioVie Inc. | -229.37 Thousand USD | 599409.87% |
| Codexis, Inc. | 57.33 Million USD | -2297.668% |
| Celularity Inc. | 6.75 Million USD | -20250.54% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -34155.644% |
| Celcuity Inc. | -142.77 Thousand USD | 962949.158% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -2717193.932% |
| Cibus, Inc. | 1.42 Million USD | -96572.222% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 367661.23% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 6097.989% |
| IN8bio, Inc. | -2.5 Million USD | 55065.174% |
| Kodiak Sciences Inc. | -25.94 Million USD | 5398.027% |
| Annexon, Inc. | -3.26 Million USD | 42177.717% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 67354.354% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 3393.67% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -214693.594% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -76.577% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -694.819% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 72451.526% |
| Arcellx, Inc. | 108.27 Million USD | -1169.571% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 4346.9% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -1635.618% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 6599.05% |
| Moolec Science SA | -143.3 Thousand USD | 959367.995% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 3348.45% |
| Geron Corporation | -123.5 Million USD | 1213.073% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -41721.692% |
| Royalty Pharma plc | 1.79 Billion USD | 23.369% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 2061.305% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 38058765.559% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -593993.547% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1333.848% |
| Humacyte, Inc. | -76.55 Million USD | 1895.792% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 144928.978% |
| 89bio, Inc. | -273 Thousand USD | 503645.421% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 109461.893% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 162208.373% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 1117725.203% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -122748.883% |
| Notable Labs, Ltd. | 113 Thousand USD | -1216430.088% |
| Liquidia Corporation | 14.6 Million USD | -9315.61% |
| Mustang Bio, Inc. | -2.22 Million USD | 61883.326% |
| Immunovant, Inc. | -231 Thousand USD | 595199.134% |
| Quantum-Si incorporated | 488 Thousand USD | -281596.516% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 2574.269% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 4582363.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -73728.088% |
| Acasti Pharma Inc. | -11 Thousand USD | 12497181.818% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 671930.298% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 212093.295% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 920.645% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -121061.928% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 360908.136% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 70308.325% |
| PepGen Inc. | -1.18 Million USD | 116204.645% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 1082524.409% |
| United Therapeutics Corporation | 2.07 Billion USD | 33.59% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 6103.752% |
| Solid Biosciences Inc. | -76.56 Million USD | 1895.487% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 1664702.884% |
| Immuneering Corporation | -764.13 Thousand USD | 179999.311% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -2074448.775% |
| Belite Bio, Inc | -399 Thousand USD | 344631.078% |
| XOMA Corporation | 3.86 Million USD | -35504.222% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 6961.045% |
| Bionomics Limited | -434.44 Thousand USD | 316518.958% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 128096.182% |
| uniQure N.V. | 2.21 Million USD | -61962.257% |
| Cassava Sciences, Inc. | -89.42 Million USD | 1637.277% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 1593.096% |
| Forte Biosciences, Inc. | -9000.00 USD | 15274311.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 164732.216% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 314671.854% |
| Altimmune, Inc. | -65.37 Million USD | 2202.824% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -279.714% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 128096.182% |
| Compugen Ltd. | 31.45 Million USD | -4270.304% |
| Peak Bio, Inc. | 367.76 Thousand USD | -373688.71% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -5507.273% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1272750.926% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 1762508.974% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 114370.906% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 75548.902% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 1155292.437% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 114370.906% |
| Instil Bio, Inc. | -4.75 Million USD | 29004.1% |
| argenx SE | 1.1 Billion USD | -24.015% |
| Immunome, Inc. | -8.9 Million USD | 15533.693% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 72834.339% |
| Verona Pharma plc | -679.62 Thousand USD | 202370.52% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 785630.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 57738.532% |
| CervoMed Inc. | -1.29 Million USD | 106365.485% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 57211.716% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 28877.036% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -55532.497% |
| Moolec Science SA | -143.3 Thousand USD | 959367.995% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 337006.355% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 51556.657% |
| AnaptysBio, Inc. | 14.78 Million USD | -9200.311% |
| Design Therapeutics, Inc. | -537 Thousand USD | 256092.365% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 322038.876% |
| NeurAxis, Inc. | 2.15 Million USD | -63639.809% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -63957.735% |
| Lumos Pharma, Inc. | 2 Million USD | -68394.22% |
| Achilles Therapeutics plc | -4.73 Million USD | 29155.198% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 785630.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1300955.453% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -4242.177% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -159356.099% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 133305.329% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 3118.089% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -3196827.907% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 167335.888% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 10447576.82% |
| Palisade Bio, Inc. | 246 Thousand USD | -558712.602% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 4165793.939% |
| Beam Therapeutics Inc. | -59.67 Million USD | 2403.725% |
| Neurogene Inc. | -3.26 Million USD | 42242.213% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -886.6% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 37333.992% |
| Sesen Bio, Inc. | 40 Million USD | -3336.698% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 462954.882% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 34236.24% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 14470.468% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -9663.345% |
| Athira Pharma, Inc. | -969 Thousand USD | 141965.738% |
| Vaccinex, Inc. | -16 Million USD | 8689.596% |
| HCW Biologics Inc. | -574.82 Thousand USD | 239247.809% |
| XOMA Corporation | 3.86 Million USD | -35504.222% |
| Nektar Therapeutics | 53.47 Million USD | -2470.551% |
| Arvinas, Inc. | 71.8 Million USD | -1814.595% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 1747.091% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 2289.851% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 427018.944% |
| Rezolute, Inc. | -36 Thousand USD | 3818652.778% |
| Clene Inc. | 533 Thousand USD | -257813.508% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 107062327.414% |
| BeyondSpring Inc. | 1.75 Million USD | -78408.224% |
| Synlogic, Inc. | -1.92 Million USD | 71549.012% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 3715448.649% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 21810.028% |
| Peak Bio, Inc. | 367.76 Thousand USD | -373688.71% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 7349.27% |
| Krystal Biotech, Inc. | 47.6 Million USD | -2787.678% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -874.321% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -27256.796% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 53192.419% |
| MannKind Corporation | 136.19 Million USD | -909.376% |
| Ikena Oncology, Inc. | -50.49 Million USD | 2822.568% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -1163.329% |
| Gossamer Bio, Inc. | -4.38 Million USD | 31449.578% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 545607.54% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 27493680.0% |
| Legend Biotech Corporation | 140.92 Million USD | -875.441% |
| Mural Oncology plc | -2.56 Million USD | 53651.967% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 249588.022% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 1374779.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -6523.682% |
| REGENXBIO Inc. | 53.02 Million USD | -2492.316% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 25761.584% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 714682.976% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 79469.457% |
| Vaxart, Inc. | -60.76 Million USD | 2362.362% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 523229.234% |
| Cellectis S.A. | 18 Thousand USD | -7637005.556% |
| Longeveron Inc. | 221 Thousand USD | -621926.697% |
| Repare Therapeutics Inc. | -80.07 Million USD | 1816.847% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -25.772% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 106334.853% |
| Revolution Medicines, Inc. | -399.66 Million USD | 443.959% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 3927754.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -2805367.347% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 84.028% |
| Denali Therapeutics Inc. | -93.34 Million USD | 1572.686% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 5488059.599% |
| Veru Inc. | 7.56 Million USD | -18069.338% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 910483.444% |
| Cingulate Inc. | -582.91 Thousand USD | 235927.166% |
| Passage Bio, Inc. | -3.72 Million USD | 37043.805% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 11413907.705% |
| Exicure, Inc. | -1.42 Million USD | 96704.287% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 359024.021% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -50757.529% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 268238.489% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -1917.848% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 918960.08% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 2421.858% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -351480.307% |
| OmniAb, Inc. | 14.66 Million USD | -9272.598% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -6775.802% |
| Lipocine Inc. | -2.85 Million USD | 48320.511% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 74689.202% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 24196.039% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 91362.512% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -1725.215% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 2114990.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -1530.776% |
| Ocugen, Inc. | -33.53 Million USD | 4198.992% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 43574.984% |
| Q32 Bio Inc. | 578 Thousand USD | -237733.737% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 518846.792% |
| Alumis Inc. Common Stock | -1.28 Million USD | 107162.227% |
| Equillium, Inc. | 35.95 Million USD | -3723.013% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 80631.869% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -274462.944% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 33253099.516% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 530864.093% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -325104.631% |
| Dominari Holdings Inc. | 2.03 Million USD | -67319.274% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 749362.281% |
| vTv Therapeutics Inc. | -13.59 Million USD | 10211.651% |
| Bio-Techne Corporation | 773.07 Million USD | -77.82% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -7837.404% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -198.333% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 117694.44% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 5832.606% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -11652.407% |
| Nkarta, Inc. | -5.86 Million USD | 23522.713% |
| BioCardia, Inc. | -7.24 Million USD | 19063.705% |
| Iterum Therapeutics plc | -1.75 Million USD | 78653.086% |